Simple and reliable2.
The CONTOUR®NEXT system offers the reliability you expect from an Ascensia product.
Easy to use
The CONTOUR®NEXT meter and test strip - ready to use right out of the box.*1
The CONTOUR®NEXT system provides reliable readings2 in 3 simple steps:
- Insert the CONTOUR®NEXT test strip and the meter turns on.
- The blood is drawn into the test strip
- View readings
Meters that are designed with patients in mind may help improve self-management and quality of life1
No need for hand written glucose diary. Use the electronic diary for a simple overview of your test readings. Download the free CONTOUR®DIABETES app today*
*On a compatible android or iOS device. To see compatibility please visit compatibility.contourone.com
The information brought to you by Ascensia Diabetes Care provides general information. It is not intended to be used as medical advice, diagnosis or treatment and should not replace the advice of your Healthcare Provider.
References:
1) Stedman M et al. J Diabetes Sci Technol. 2020 Mar 14; doi: 10.1177/1932296820905880. Online ahead of print. 2) CONTOUR®NEXT User Guide (connected) BGMS User Guide, Rev. 05/19. 3) Grady M et al. J Diabetes Sci Technol. 2018;12:1211–1219. 4) Data on File. N=326. Ascensia Diabetes care. CNext/CTV3 Study. Protocol no. GCA-PRO-2018-006-01 5) Richardson J et al. Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the virtual 20th Annual Diabetes Technology Meeting (DTM). 12 November 2020.
©2021 Ascensia Diabetes Care Holdings AG. All rights reserved. Ascensia, the Ascensia Diabetes Care logo, Contour, smartLIGHT and Second-Chance are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG.Apple and the Apple logo are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Date of preparation: February 2021. PP-CN-Mtr-GBL-0003
Easy to understand
The easy to understand smartLIGHT® target range indicator shows if the blood glucose reading is within a personal target range.**2
Amber
Above Target Range
Green
Within Target Range
Red
Below Target Range
96% of people with diabetes think that a meter with amber, green and red colour coding are easy to understand4
Readings that use colour can assist people with diabetes in reaching their HbA1c target3
No need for hand written glucose diary. Use the electronic diary for a simple overview of your test readings. Download the free CONTOUR®DIABETES app today*
*On a compatible android or iOS device. To see compatibility please visit compatibility.contourone.com
**Always consult your healthcare professional before setting or changing any target ranges
The information brought to you by Ascensia Diabetes Care provides general information. It is not intended to be used as medical advice, diagnosis or treatment and should not replace the advice of your Healthcare Provider.
References:
1) Stedman M et al. J Diabetes Sci Technol. 2020 Mar 14; doi: 10.1177/1932296820905880. Online ahead of print. 2) CONTOUR®NEXT User Guide (connected) BGMS User Guide, Rev. 05/19. 3) Grady M et al. J Diabetes Sci Technol. 2018;12:1211–1219. 4) Data on File. N=326. Ascensia Diabetes care. CNext/CTV3 Study. Protocol no. GCA-PRO-2018-006-01 5) Richardson J et al. Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the virtual 20th Annual Diabetes Technology Meeting (DTM). 12 November 2020.
©2021 Ascensia Diabetes Care Holdings AG. All rights reserved. Ascensia, the Ascensia Diabetes Care logo, Contour, smartLIGHT and Second-Chance are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG.Apple and the Apple logo are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Date of preparation: February 2021. PP-CN-Mtr-GBL-0003
Easy to avoid re-lancing
Second-Chance® sampling allows 60 seconds to apply more blood to the same strip if the first sample is not enough, avoiding relancing.2
93% of people with diabetes surveyed prefer a blood glucose meter with the ability to re-apply blood to the same test strips4
Second-Chance® sampling may reduce the need to re-lance and prevent waste of test strips in certain target groups5
No need for hand written glucose diary. Use the electronic diary for a simple overview of your test readings. Download the free CONTOUR®DIABETES app today*
*On a compatible android or iOS device. To see compatibility please visit compatibility.contourone.com
The information brought to you by Ascensia Diabetes Care provides general information. It is not intended to be used as medical advice, diagnosis or treatment and should not replace the advice of your Healthcare Provider.
References:
1) Stedman M et al. J Diabetes Sci Technol. 2020 Mar 14; doi: 10.1177/1932296820905880. Online ahead of print. 2) CONTOUR®NEXT User Guide (connected) BGMS User Guide, Rev. 05/19. 3) Grady M et al. J Diabetes Sci Technol. 2018;12:1211–1219. 4) Data on File. N=326. Ascensia Diabetes care. CNext/CTV3 Study. Protocol no. GCA-PRO-2018-006-01 5) Richardson J et al. Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the virtual 20th Annual Diabetes Technology Meeting (DTM). 12 November 2020.
©2021 Ascensia Diabetes Care Holdings AG. All rights reserved. Ascensia, the Ascensia Diabetes Care logo, Contour, smartLIGHT and Second-Chance are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG.Apple and the Apple logo are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Date of preparation: February 2021. PP-CN-Mtr-GBL-0003
Simply accurate
Accurate test readings are important for therapy decisions, especially for the correct insulin dose calculation.1
The CONTOUR®NEXT system has demonstrated highly accurate readings.2
No need for hand written glucose diary. Use the electronic diary for a simple overview of your test readings. Download the free CONTOUR®DIABETES app today*
*On a compatible android or iOS device. To see compatibility please visit compatibility.contourone.com
The information brought to you by Ascensia Diabetes Care provides general information. It is not intended to be used as medical advice, diagnosis or treatment and should not replace the advice of your Healthcare Provider.
References:
1) Stedman M et al. J Diabetes Sci Technol. 2020 Mar 14; doi: 10.1177/1932296820905880. Online ahead of print. 2) CONTOUR®NEXT User Guide (connected) BGMS User Guide, Rev. 05/19. 3) Grady M et al. J Diabetes Sci Technol. 2018;12:1211–1219. 4) Data on File. N=326. Ascensia Diabetes care. CNext/CTV3 Study. Protocol no. GCA-PRO-2018-006-01 5) Richardson J et al. Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the virtual 20th Annual Diabetes Technology Meeting (DTM). 12 November 2020.
©2021 Ascensia Diabetes Care Holdings AG. All rights reserved. Ascensia, the Ascensia Diabetes Care logo, Contour, smartLIGHT and Second-Chance are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG.Apple and the Apple logo are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Date of preparation: February 2021. PP-CN-Mtr-GBL-0003
